Absci Corp (ABSI)
4.62
-0.12
(-2.53%)
USD |
NASDAQ |
May 17, 16:00
4.62
0.00 (0.00%)
After-Hours: 20:00
Absci Shareholders Equity (Quarterly): 240.11M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 240.11M |
December 31, 2023 | 176.18M |
September 30, 2023 | 196.42M |
June 30, 2023 | 215.40M |
March 31, 2023 | 253.96M |
December 31, 2022 | 274.41M |
September 30, 2022 | 292.94M |
Date | Value |
---|---|
June 30, 2022 | 316.19M |
March 31, 2022 | 340.50M |
December 31, 2021 | 366.11M |
September 30, 2021 | 388.01M |
June 30, 2021 | 37.12M |
March 31, 2021 | -98.50M |
December 31, 2020 | -89.43M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-98.50M
Minimum
Mar 2021
388.01M
Maximum
Sep 2021
207.82M
Average
247.04M
Median
Shareholders Equity (Quarterly) Benchmarks
Eli Lilly and Co | 12.81B |
Recursion Pharmaceuticals Inc | 401.15M |
Creative Medical Technology Holdings Inc | 9.229M |
CytomX Therapeutics Inc | -31.68M |
HOOKIPA Pharma Inc | 104.52M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 274.90M |
Total Liabilities (Quarterly) | 34.79M |
Debt to Equity Ratio | 0.0293 |
Current Ratio | 7.189 |
Net Debt Paydown Yield | 0.12% |